Valuation: Cutia Therapeutics

Market Cap 342M 400M 51M 44.97M 42.53M 38.53M 72.37M 4.89B 73.02M 509M 196M 2.5B 191M 187M 8.02B P/E 2026 *
31.4x
P/E 2027 * 6.72x
Enterprise Value 342M 400M 51M 44.97M 42.53M 38.53M 72.37M 4.89B 73.02M 509M 196M 2.5B 191M 187M 8.02B EV / Sales 2026 *
0.58x
EV / Sales 2027 * 0.36x
Free-Float
32.66%
Yield 2026 *
-
Yield 2027 * -
1 day+22.22%
1 week-7.56%
Current month-42.41%
1 month-43.73%
3 months-59.26%
6 months-76.89%
Current year-75.77%
1 week 0.74
Extreme 0.74
1.33
1 month 0.74
Extreme 0.74
1.97
Current year 0.74
Extreme 0.74
5.51
1 year 0.74
Extreme 0.74
9.19
3 years 0.74
Extreme 0.74
24
5 years 0.74
Extreme 0.74
32.6
10 years 0.74
Extreme 0.74
32.6
Manager TitleAgeSince
Chief Executive Officer 48 31/08/2019
Director of Finance/CFO 36 09/05/2021
Chief Tech/Sci/R&D Officer 42 09/01/2020
Director TitleAgeSince
Director/Board Member 48 11/05/2020
Chairman 63 22/08/2019
Director/Board Member 36 14/11/2022
Date Insider Type Main position Quantity % Market Cap. Importance
15/10/24 Other

Founder

15,000 0.0049%
03/10/24 Other

Chief Financial Officer

20,000 0.0066%
02/10/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
+22.22%-7.56%-87.40%-94.42% 41.69M
-0.01%+1.69%+63.50%+117.58% 1,056B
-1.61%-0.71%+48.89%+70.56% 655B
-1.12%-0.45%+19.35%+72.93% 471B
-1.72%-4.25%+37.79%+39.89% 342B
-0.40%+4.12%+22.89%+29.04% 277B
-0.51%-1.05%+12.98%+12.92% 257B
+1.32%+7.75%+55.19%+56.43% 226B
-0.61%+0.48%+34.95%+100.58% 189B
-0.24%-3.21%-27.79%-61.37% 170B
Average +1.73%+0.84%+18.03%+34.41% 364.29B
Weighted average by Cap. -0.63%+0.76%+39.85%+68.92%

Financials

2026 *2027 *
Net sales 588M 688M 87.72M 77.35M 73.15M 66.28M 124M 8.42B 126M 876M 338M 4.3B 329M 322M 13.8B 961M 1.12B 143M 126M 120M 108M 203M 13.76B 205M 1.43B 552M 7.03B 538M 527M 22.55B
Net income 10M 11.7M 1.49M 1.32M 1.24M 1.13M 2.12M 143M 2.14M 14.9M 5.75M 73.13M 5.6M 5.48M 235M 50M 58.52M 7.46M 6.58M 6.22M 5.64M 10.59M 716M 10.68M 74.52M 28.73M 366M 28.01M 27.4M 1.17B
Net Debt - -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
268
Date Price Change Volume
29/09/26 HK$1.100 +22.22% 2,176,800
28/09/26 HK$0.9000 -4.76% 4,018,400
25/09/26 HK$0.9450 -10.00% 235,200
24/09/26 HK$1.050 -0.94% 1,664,200
23/09/26 HK$1.060 -5.78% 233,400
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9408CNY
Average target price
6.572CNY
Spread / Average Target
+598.58%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock